| Structure |
Chemical Name |
CAS |
MF |
 |
4(1H)-Pyridinone, 1-(6-methoxy-1H-benzimidazol-2-yl)-2,3,5-trimethyl- |
2512216-37-2 |
C16H17N3O2 |
 |
Budesonide Impurity 31 |
|
|
 |
Budesonide Impurity 23 |
|
|
 |
Hexanoic acid, 3-(chloromethyl)-, (3R)- |
2101641-90-9 |
C7H13ClO2 |
 |
Bisoprolol Impurity |
2226263-68-7 |
C18H31NO4 |
![2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)-](/CAS/20210111/GIF/1261219-83-3.gif) |
2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)- |
1261219-83-3 |
C18H17NO4 |
 |
Tofacitinib Impurity |
2504210-41-5 |
C29H38N10O2 |
 |
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
![2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)-](/CAS/20210305/GIF/2459302-85-1.gif) |
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
 |
Avatrombopag Impurity 38 |
|
|
 |
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
 |
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
 |
6-Chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxanine-8-carboxylic acid |
123040-79-9 |
C10H8ClNO4 |
![3-Amino-3-azabicyclo[3.3.0]octane](/CAS/GIF/54528-00-6.gif) |
3-Amino-3-azabicyclo[3.3.0]octane |
54528-00-6 |
C7H14N2 |
 |
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |
![(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one](/) |
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
|
|
![(3aS-cis)-1,3-dibenzyltetrahydro-1H-thieno[3,4-d]imidazole-2,4-dione](/CAS/GIF/28092-52-6.gif) |
(3aS-cis)-1,3-dibenzyltetrahydro-1H-thieno[3,4-d]imidazole-2,4-dione |
28092-52-6 |
C19H18N2O2S |
 |
methyl L-prolinate |
2577-48-2 |
C6H11NO2 |
 |
CHLORHEXIDENE DIACETATE IMPURITY A |
152504-08-0 |
C16H24ClN9 |
 |
AZITHROMYCIN IMPURITY A |
|
|
 |
D(-)-AMETHOPTERIN |
51865-79-3 |
C20H22N8O5 |
 |
sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate |
|
|
 |
3-(((3R)-3-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)-1,4-dioxan-2-ylamino)methyl)-1H-1,2,4-triazol-5(4H)-one |
|
|
 |
2,4,6-tripropyl-1,3,5-trioxane |
2396-43-2 |
C12H24O3 |
 |
Oseltamivir Impurity 94 |
|
|
 |
Oseltamivir Impurity 82 |
|
|
 |
Oseltamivir Impurity 74 |
|
|
 |
Uridine, 5'-(2-methylpropanoate) (9CI) |
886538-48-3 |
C13H18N2O7 |
 |
Dapagliflozin Impurity 47 |
|
|
 |
Crisaborole Impurity 17 |
|
|
 |
Crisaborole Impurity 19 |
|
|
![1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]-](/CAS/20210305/GIF/2514695-40-8.gif) |
1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]- |
2514695-40-8 |
C20H18FNO4 |
 |
4-ethoxy-3-(4-pyridyl)-3-buten-2-one |
88349-61-5 |
C11H13NO2 |
 |
1,3-dihydro-4-methyl-2H-1,5-benzodiazepin-2-one |
6276-48-8 |
C10H10N2O |
 |
(E)-2-methoxy-4-(prop-1-enyl)phenol |
5932-68-3 |
C10H12O2 |
![3-amino-5-[(methylthio)methyl]oxazolidin-2-one](/CAS/GIF/25517-72-0.gif) |
3-amino-5-[(methylthio)methyl]oxazolidin-2-one |
25517-72-0 |
C5H10N2O2S |
![Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI)](/CAS/20210305/GIF/107021-20-5.gif) |
Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI) |
107021-20-5 |
C9H14N5O4P |
 |
Sitagliptin EP Impurity 7 |
|
|
 |
Sitagliptin EP Impurity H |
|
|
![7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]-](/CAS/20210305/GIF/2636673-48-6.gif) |
7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]- |
2636673-48-6 |
C18H26ClN3O4 |
 |
Beprostatin impurity 4 |
|
|
![cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole](/CAS/20180808/GIF/65621-78-5.gif) |
cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
65621-78-5 |
C17H16ClNO |
 |
methyl tosylcarbamate |
14437-03-7 |
C9H11NO4S |
![(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium](/CAS/20211123/GIF/786598-71-8.gif) |
(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium |
786598-71-8 |
C21H28NO3+ |
 |
1-(3-((2,4-dimethylphenyl)thio)phenyl)piperazine hydrochloride |
2137793-92-9 |
|
 |
Apixaban impurity 66S |
|
|
 |
Aatrombopag Impurity 17 |
1268118-96-2 |
C7H4BrClN2S2 |
 |
(R)-(-)-2-AMINOBUTANAMIDE HYDROCHLORIDE, 97% |
103765-03-3 |
C4H11ClN2O |
 |
Flomoxef Impurity 20 Sodium Salt |
2095697-77-9 |
C15H18F2N6O7S2 |
 |
((2R,3S,4R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl isobutyrate |
2591381-21-2 |
C9H16O6 |
amino]-5-(4-nitrophenyl)-, ethyl ester](/CAS/20210305/GIF/2591260-07-8.gif) |
3-Thiophenecarboxylic acid, 4-(bromomethyl)-2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-5-(4-nitrophenyl)-, ethyl ester |
2591260-07-8 |
C25H23BrF2N2O6S |
![Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel-](/CAS/20210305/GIF/190582-37-7.gif) |
Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel- |
190582-37-7 |
C23H32N4O3S |
 |
Ivabradine Impurity II |
|
|
![(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate](/CAS/20211123/GIF/792155-94-3.gif) |
(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate |
792155-94-3 |
C18H19NO4S2 |
 |
Donepezil Impurity 3 |
1023500-88-0 |
C24H27NO4 |
 |
Fesoterodine Related Impurity 4 |
214601-12-4 |
C22H29NO2 |
 |
Prasugrel Impurity 14 Maleate |
1373350-60-7 |
C24H25BrFNO7S |
 |
Sofosbuvir Impurity 32 |
1157884-58-6 |
C20H17FO6 |
 |
Torsemide Related Compound 1 |
947327-54-0 |
C13H13N3O2S |
 |
Vortioxetine Impurity 3 |
508233-82-7 |
C17H20N2S |
 |
CYCLOPENTYL BENZOATE |
32651-38-0 |
C12H14O2 |
 |
4,5-DICHLOROTHIOPHENE-2-CARBOXYLIC ACID |
31166-29-7 |
C5H2Cl2O2S |
 |
N,O-Dibenzylated formoterol |
43229-70-5 |
C33H36N2O4 |
 |
Entacapone |
|
|
 |
nifedipine iMpurity |
79781-06-9 |
C17H17N3O7 |
 |
Linagliptin Impurity A |
|
|
 |
Dehydropitavastatin ethyl ester |
254452-91-0 |
C27H26FNO4 |
 |
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide |
357338-13-7 |
C11H18N2O2 |
 |
Linagliptin Impurity V |
|
|
 |
methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate |
1181267-33-3 |
C13H17ClO2 |
 |
(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
150194-52-8 |
C11H10BrF2N3O |
![(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide](/CAS/20180703/GIF/CB93049205.gif) |
(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide |
|
C24H30ClN7O5S |
 |
Etoricoxib Impurity 18 |
|
|
 |
Ibrutinib Impurity 4 |
1807619-68-6 |
C17H12ClN5O |
 |
Imatinib Impurity 3 |
|
|
 |
Mirabegron Impurity 16 |
|
|
 |
Olaparib Impurity 2 |
|
|
 |
Sofosbuvir Impurity 7 |
1884385-12-9 |
C20H19FO6 |
 |
Vonoprazan Impurity 3 |
928325-41-1 |
C17H15F2N3O2S |
 |
Cinacalcet Impurity 22 |
|
|
 |
Dapagliflozin Impurity C |
|
|
 |
Dasatinib Impurity E |
|
|
 |
(+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl) |
147770-06-7 |
C29H40N2O4 |
 |
4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride |
152402-97-6 |
C7H8Cl3N |
 |
4-(3-CYANO-2-METHYLPROPIONYL)ACETAMILIDE |
42075-21-8 |
|
![Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime]](/CAS/GIF/119699-81-9.gif) |
Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] |
119699-81-9 |
C48H94N2O14Si2 |
 |
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)-3,7-dihydro-1H-purine-2,6-dione |
|
|
 |
Isavuconazole Impurity 37 |
|
|
 |
"mixture of 2-amino-9-[[2-(hydroxymethoxy) ethoxy]methyl]-1,9-dihydro-6H-purin-6-one and 2-amino-9-[[2-(hydroxyethoxy)methoxy]methyl]-1,9- dihydro-6H-purin-6-one," |
|
|
![N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide](/CAS/20210305/GIF/1375004-39-9.gif) |
N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
1375004-39-9 |
C29H39BN4O4 |
 |
(S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile |
|
|
 |
Mannitol EP impurity B |
|
|
 |
Mannitol EP impurity A |
|
|
 |
Peramivir Amino Carboxylic Isomerism Impurity |
|
|
 |
Peramivir Chlorinated Impurity |
|
|
 |
Brivaracetam Impurity 999 |
|
|
 |
Dasatinib impurity 48 |
|
|
 |
Pemetrexed Impurity 120 |
|
|
 |
Ticagrelor Impurity 101 |
|
|
![4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane](/) |
4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane |
|
|